Literature DB >> 55567

Letter: Bioavailability of phenytoin.

P Tammisto, K Kauko, M Viukari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 55567     DOI： 10.1016/s0140-6736(76)91382-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Is generic prescribing acceptable in epilepsy?

Authors:  F M Besag
Journal:  Drug Saf       Date:  2000-09       Impact factor: 5.606

2.  Effect of increased bioavailability of phenytoin tablets on serum phenytoin concentration in epileptic out-patients.

Authors:  P J Neuvonen; A Bardy; R Lehtovaara
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

3.  [Selected clinical aspects of routine monitoring of anticonvulsant concentrations in serum (author's transl)].

Authors:  R Heipertz; H Pilz; K Eickhoff; D Seidel
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

4.  Bioavailability and dissolution of proprietary and generic formulations of phenytoin.

Authors:  I Soryal; A Richens
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

5.  Impact of generic substitution of anticonvulsants on the treatment of epilepsy.

Authors:  A Richens
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

6.  Bioavailability of three phenytoin preparations in healthy subjects and in epileptics.

Authors:  B Rambeck; H E Boenigk; E Stenzel
Journal:  Eur J Clin Pharmacol       Date:  1977-12-02       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of phenytoin.

Authors:  A Richens
Journal:  Clin Pharmacokinet       Date:  1979 May-Jun       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.